Vyondys 53 (Golodirsen)
- Medicine Name: Vyondys 53
- Generic Name: Golodirsen
- Dosage Form & Strength: Injection: 100 mg/2 mL (50 mg/mL)
- Manufactured By: Sarepta Therapeutics, Inc.
Vyondys 53 is an antisense oligonucleotide used for the treatment of Duchenne muscular dystrophy (DMD) in patients (adults and children) who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Recommended Dosage: The recommended dosage of Vyondys 53 injection is 30 milligrams per kilogram administered once weekly as a 35-60 minute intravenous infusion via an in-line 0.2 micron filter. If a dose is missed, it may be administered as promptly as possible after the scheduled dose.
- Urine dipstick, serum cystatin C, and urine protein-to-creatinine ratio should be measured prior to starting Vyondys 53 therapy. Consider measurement of glomerular filtration rate prior to initiation of this therapy.
- Monitoring for kidney toxicity is required during therapy with Vyondys 53 (Golodirsen Injection). Obtain the urine samples before the infusion of this injection or at least 48 hours after the most recent infusion.
- Hypersensitivity reactions, including pyrexia, rash, pruritus, dermatitis, urticaria, and skin exfoliation have appeared in Golodirsen-treated patients. If a hypersensitivity reaction appears, institute apt medical treatment and slow the infusion or interrupt the therapy.
- It isn’t specified if it’s safe to take Golodirsen 100 mg/2 mL injection while pregnant. This is because this drug hasn’t been evaluated during pregnancy. If you’re pregnant or want to become pregnant, talk with your health specialist about the risks and benefits of using this medicine.
- It’s unspecified whether it’s safe to take Vyondys 53 treatment while breastfeeding. In case you’re currently breastfeeding or want to breastfeed, talk with your health specialist about the risks and benefits of using this medicinal product.
What documents are required to import VYONDYS 53 to India?
VYONDYS 53 (Golodirsen Injection) can be imported by patients or government hospitals on the name of the patients only.
The following documentation needed in order to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is VYONDYS 53 available in India?
VYONDYS 53 (golodirsen) injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability golodirsen in India (Ahmedabad, Mumbai, Kolkata, Hyderabad, Chennai, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from Europe, Australia, Canada and USA.
- Ensuring 100% transparency.
VYONDYS 53 can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of VYONDYS 53 (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for vyondys 53 price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.